NO344476B1 - Fremgangsmåte og inretning for behandling av mikroskopiske rester av tumorer som er igjen i vev etter kirurgisk fjerning - Google Patents

Fremgangsmåte og inretning for behandling av mikroskopiske rester av tumorer som er igjen i vev etter kirurgisk fjerning Download PDF

Info

Publication number
NO344476B1
NO344476B1 NO20084148A NO20084148A NO344476B1 NO 344476 B1 NO344476 B1 NO 344476B1 NO 20084148 A NO20084148 A NO 20084148A NO 20084148 A NO20084148 A NO 20084148A NO 344476 B1 NO344476 B1 NO 344476B1
Authority
NO
Norway
Prior art keywords
tumor
tissue
bleomycin
treatment
agent
Prior art date
Application number
NO20084148A
Other languages
English (en)
Norwegian (no)
Other versions
NO20084148L (no
Inventor
Paul Goldfarb
Dietmar Rabussay
Original Assignee
Oncosec Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncosec Medical Inc filed Critical Oncosec Medical Inc
Publication of NO20084148L publication Critical patent/NO20084148L/no
Publication of NO344476B1 publication Critical patent/NO344476B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/327—Applying electric currents by contact electrodes alternating or intermittent currents for enhancing the absorption properties of tissue, e.g. by electroporation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surgical Instruments (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
NO20084148A 2006-03-03 2008-10-01 Fremgangsmåte og inretning for behandling av mikroskopiske rester av tumorer som er igjen i vev etter kirurgisk fjerning NO344476B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77874006P 2006-03-03 2006-03-03
PCT/US2007/005133 WO2007103070A2 (en) 2006-03-03 2007-03-02 Method and device for treating microscopic residual tumors remaining in tissues following surgical resection

Publications (2)

Publication Number Publication Date
NO20084148L NO20084148L (no) 2008-11-13
NO344476B1 true NO344476B1 (no) 2020-01-13

Family

ID=38475369

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20084148A NO344476B1 (no) 2006-03-03 2008-10-01 Fremgangsmåte og inretning for behandling av mikroskopiske rester av tumorer som er igjen i vev etter kirurgisk fjerning
NO20191102A NO20191102A1 (no) 2006-03-03 2019-09-13 Fremgangsmåte og innretning for behandling av mikroskopiske resttumorer som er igjen i vev etter kirurgisk fjerning

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20191102A NO20191102A1 (no) 2006-03-03 2019-09-13 Fremgangsmåte og innretning for behandling av mikroskopiske resttumorer som er igjen i vev etter kirurgisk fjerning

Country Status (12)

Country Link
US (4) US9037230B2 (enExample)
EP (2) EP1991303B1 (enExample)
JP (3) JP2009528131A (enExample)
KR (2) KR101529448B1 (enExample)
CN (2) CN102921102B (enExample)
AU (1) AU2007224275B2 (enExample)
CA (1) CA2644163C (enExample)
DK (1) DK1991303T3 (enExample)
ES (1) ES2874482T3 (enExample)
NO (2) NO344476B1 (enExample)
PL (1) PL1991303T3 (enExample)
WO (1) WO2007103070A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101529448B1 (ko) 2006-03-03 2015-06-18 온코섹 메디컬 인코포레이티드 외과적 절제술 이후에 조직내 남아 있는 미세 잔류 종양을 치료하는 장치
ES2868136T3 (es) * 2007-08-14 2021-10-21 Hutchinson Fred Cancer Res Disposición de matriz de agujas y método para administrar agentes terapéuticos
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
EP2280741A4 (en) 2008-04-29 2012-06-13 Virginia Tech Intell Prop IRREVERSIBLE ELECTROPORATION FOR THE PRODUCTION OF TISSUE OBJECTS
WO2009155526A2 (en) * 2008-06-20 2009-12-23 Angiodynamics, Inc. Device and method for the ablation of fibrin sheath formation on a venous catheter
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
CA2689400C (en) * 2009-12-30 2023-01-10 Kenneth W. Adams Therapeutic agent delivery apparatus and process
KR102593818B1 (ko) 2010-04-28 2023-10-25 이노비오 파마수티컬즈, 인크. 구강 점막 전기천공 장치 및 그 용도
US9700368B2 (en) 2010-10-13 2017-07-11 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
CN103717249B (zh) 2011-06-15 2017-03-22 克洛恩泰克制药股份公司 注射针和装置
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
EP2771043A4 (en) 2011-10-28 2015-04-29 Presage Biosciences Inc ACTIVE RELEASE PROCEDURE
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US10166321B2 (en) 2014-01-09 2019-01-01 Angiodynamics, Inc. High-flow port and infusion needle systems
WO2015175570A1 (en) 2014-05-12 2015-11-19 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US10287543B2 (en) * 2015-11-19 2019-05-14 Miltenyi Biotec, Gmbh Process and device for isolating cells from biological tissue
US20170232253A1 (en) * 2016-02-16 2017-08-17 Marcy C. Purnell Bioelectrodynamics Modulation Method
CA3029260A1 (en) 2016-06-27 2018-01-04 Gala Therapeutics, Inc. Generator and a catheter with an electrode and a method for treating a lung passageway
US12403305B2 (en) 2016-06-27 2025-09-02 Galvanize Therapeutics, Inc. Immunostimulation in the treatment of viral infection
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
JP2021502882A (ja) 2017-11-15 2021-02-04 アルキオーネ・ライフサイエンシズ・インコーポレイテッドＡｌｃｙｏｎｅ Ｌｉｆｅｓｃｉｅｎｃｅｓ， Ｉｎｃ． 治療法別の事前プログラムされた自動注射デバイス
EP3710102A4 (en) * 2017-11-17 2021-08-04 AbbVie Inc. METHOD OF TREATMENT OF GLIOBLASTOMA
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
CA3087183A1 (en) 2017-12-26 2019-07-04 Galary, Inc. Optimization of energy delivery for various applications
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US12390262B2 (en) 2018-03-13 2025-08-19 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
TWI850282B (zh) 2018-11-27 2024-08-01 香港商弘年發展有限公司 用於治療癌症之質體建構體和使用方法
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
JP7586890B2 (ja) 2019-07-16 2024-11-19 ガルヴァナイズ セラピューティクス，インコーポレイテッド パルス電界による生殖器の治療
US12214189B2 (en) 2019-07-24 2025-02-04 Virginia Tech Intellectual Properties, Inc. Fourier analysis spectroscopy for monitoring tissue impedance changes and treatment outcome during electroporation-based-therapies
US12485279B2 (en) 2020-11-25 2025-12-02 Virginia Tech Intellectual Properties, Inc. Methods for modulating temporal infrastructure of pulsed electric fields
CN116509535B (zh) * 2023-03-14 2024-01-23 武汉金柏威光电技术有限公司 一种医用高频电刀

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142606A2 (en) * 2000-04-06 2001-10-10 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
US20050054969A1 (en) * 2001-03-13 2005-03-10 University Of South Florida Electromanipulation Device and Method
US20060024358A1 (en) * 2004-07-30 2006-02-02 Santini John T Jr Multi-reservoir device for transdermal drug delivery and sensing

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US20030060434A1 (en) * 1997-02-18 2003-03-27 Loretta Nielsen Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
AU8444698A (en) 1997-06-30 1999-01-25 Centre National De La Recherche Scientifique Improved method for transferring nucleic acid into multicelled eukaryo tic organism cells and combination therefor
US6055453A (en) * 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
WO1999037538A2 (en) 1998-01-26 1999-07-29 Simula Inc. Parachute landing velocity attenuator
US6208893B1 (en) 1998-01-27 2001-03-27 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6104584A (en) * 1999-02-18 2000-08-15 Lucent Technologies, Inc. Voltage feedback inrush current limit circuit having increased tolerance for component value variation
CA2391594A1 (en) * 1999-12-23 2001-06-28 Human Genome Sciences, Inc. Trefoil domain-containing polynucleotides, polypeptides, and antibodies
ATE511400T1 (de) 2000-03-03 2011-06-15 Genetronics Inc Nukleinsäure-fomulierungen zur genverabreichung
US20040092860A1 (en) * 2000-07-26 2004-05-13 Dev Nagendu B. Skin and muscle-targeted gene therapy by pulsed electrical field
JP2005513062A (ja) * 2001-12-14 2005-05-12 ジェネトロニクス インコーポレイテッド パルス電場を使用した粒子支援ポリヌクレオチド免疫方法
JP2005518904A (ja) * 2002-03-07 2005-06-30 マーク アンド カンパニー インコーポレイテッド 電気的刺激の側面を備えた臨床用注射器
US8209006B2 (en) * 2002-03-07 2012-06-26 Vgx Pharmaceuticals, Inc. Constant current electroporation device and methods of use
US7901879B2 (en) * 2002-05-10 2011-03-08 Agennix Incorporated Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
US20040014645A1 (en) 2002-05-28 2004-01-22 Advisys, Inc. Increased delivery of a nucleic acid construct in vivo by the poly-L-glutamate ("PLG") system
JP4409239B2 (ja) * 2003-09-18 2010-02-03 テルモ株式会社 薬液注入装置
US7234824B2 (en) * 2003-09-22 2007-06-26 Langley Nicholas M Glare-elimination device for surgical microscopes
US20050209625A1 (en) * 2004-03-02 2005-09-22 Chan Frank A Method and apparatus for electrical stimulation to enhance lancing device performance
US20070088345A1 (en) 2005-10-13 2007-04-19 Ust Inc. Applications of HIFU and chemotherapy
KR101529448B1 (ko) 2006-03-03 2015-06-18 온코섹 메디컬 인코포레이티드 외과적 절제술 이후에 조직내 남아 있는 미세 잔류 종양을 치료하는 장치
US7671095B2 (en) * 2006-05-31 2010-03-02 The Trustees Of The Boston University Films and particles
PL2409727T3 (pl) * 2006-10-17 2019-03-29 Inovio Pharmaceuticals, Inc. Urządzenia elektroporacyjne do elektroporacji komórek u ssaków

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1142606A2 (en) * 2000-04-06 2001-10-10 Varian Medical Systems, Inc. Multipurpose template and needles for the delivery and monitoring of multiple minimally invasive therapies
US20050054969A1 (en) * 2001-03-13 2005-03-10 University Of South Florida Electromanipulation Device and Method
US20060024358A1 (en) * 2004-07-30 2006-02-02 Santini John T Jr Multi-reservoir device for transdermal drug delivery and sensing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Li, S. et al., "Regression of Tumor Growth and Induction of Long-Term Antitumor Memory by Interleukin 12 Electro-Gene Therapy", JNCI: Journal of the National Cancer Institute, Volume 94, Issue 10, 15 May 2002, pages 762–768, Published: 15 May 2002 [Hentet fra Internett 2017.11.06] (https://academic.oup.com/jnci/article/94/10/762/2519724), Dated: 01.01.0001 *

Also Published As

Publication number Publication date
US20120143120A1 (en) 2012-06-07
WO2007103070A3 (en) 2008-08-28
WO2007103070A2 (en) 2007-09-13
KR101444471B1 (ko) 2014-09-24
US9037230B2 (en) 2015-05-19
EP1991303B1 (en) 2021-05-05
CN102921102B (zh) 2015-06-10
KR20090004890A (ko) 2009-01-12
US20070239099A1 (en) 2007-10-11
JP2015213778A (ja) 2015-12-03
NO20191102A1 (no) 2008-11-13
US11007365B2 (en) 2021-05-18
US20210308451A1 (en) 2021-10-07
CN101426550B (zh) 2012-10-31
CA2644163C (en) 2020-05-05
EP3845269A1 (en) 2021-07-07
AU2007224275A1 (en) 2007-09-13
US20170216585A1 (en) 2017-08-03
KR20140081894A (ko) 2014-07-01
KR101529448B1 (ko) 2015-06-18
DK1991303T3 (da) 2021-06-07
AU2007224275B2 (en) 2012-04-12
JP6174632B2 (ja) 2017-08-02
EP1991303A4 (en) 2012-01-18
EP1991303A2 (en) 2008-11-19
JP2009528131A (ja) 2009-08-06
US12324913B2 (en) 2025-06-10
PL1991303T3 (pl) 2021-10-11
NO20084148L (no) 2008-11-13
JP2013127000A (ja) 2013-06-27
ES2874482T3 (es) 2021-11-05
CN102921102A (zh) 2013-02-13
CN101426550A (zh) 2009-05-06
CA2644163A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
NO20191102A1 (no) Fremgangsmåte og innretning for behandling av mikroskopiske resttumorer som er igjen i vev etter kirurgisk fjerning
US11497544B2 (en) Immunologic treatment of cancer
US10252004B2 (en) Method and apparatus for delivery of therapeutic agents
Ramirez et al. Electrochemotherapy on liver tumours in rabbits
Kis et al. Electrochemotherapy of cutaneous metastases of melanoma—a case series study and systematic review of the evidence
JP2009528131A5 (enExample)
WO2019075380A1 (en) TARGETED ADMINISTRATION OF BIOLOGICAL THERAPEUTIC AGENTS
HK40046842A (en) Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
AU2012201850A1 (en) Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
Heller et al. Medical Applications
Deore et al. Elecrochemotherapy: An enhancement of cytotoxicity of anticancer drugs
Ronchetti et al. Bone Tissue Electroporation: Implications for Treatment of Bone Metastasis
Cadossi et al. Electroporation of bone tissue: implications for Use in the treatment of bone metastasis with electrochemotherapy
CN108042494A (zh) 射频消融术联合脂质体药物治疗心律失常的方法
WO2019095189A1 (zh) 一种陡脉冲电场肿瘤治疗电极

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ONCOSEC MEDICAL INCORPORATED, US